Preparing individual patient data from clinical trials for sharing: The GlaxoSmithKline approach

Pharmaceutical Statistics

Volumn 13, Issue 3, 2014, Pages 179-183

  Hughes, Sara ^a   Wells, Karen ^a   McSorley, Paul ^b   Freeman, Andrew ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b GLAXOSMITHKLINE   (United States)

Author keywords

data anonymisation; data sharing; privacy; transparency

Indexed keywords

ACCESS TO INFORMATION; ARTICLE; CLINICAL TRIAL (TOPIC); CONFIDENTIALITY; FOLLOW UP; HEALTH INSURANCE; HUMAN; MEDICAL HISTORY; MEDICAL INFORMATION; ONLINE SYSTEM; PATIENT CARE; PATIENT CODING; PRIVACY; QUALITY CONTROL; DRUG INDUSTRY; INFORMATION DISSEMINATION; PERSONNEL; PROCEDURES;

ACCESS TO INFORMATION; CLINICAL TRIALS AS TOPIC; CONFIDENTIALITY; DRUG INDUSTRY; HUMANS; INFORMATION DISSEMINATION; ONLINE SYSTEMS; RESEARCH PERSONNEL;

EID: 84901195575     PISSN: 15391604     EISSN: 15391612     Source Type: Journal    
DOI: 10.1002/pst.1615     Document Type: Article

References (14)

1. th November 2013.
2. Godlee F,. Clinical trial data for all drugs in current use. British Medical Journal 2012; 345: 7-10.
3. nd November 2013.
4. nd November 2013.
5. Nisen P, Rockhold F,. Access to patient-level data from GlaxoSmithKline clinical trials. New England Journal of Medicine 2013; 369: 475-478.
6. th November 2013.
7. nd November 2013.
8. Vallance P, Chalmers I,. Secure use of individual patient data from clinical trials. Lancet 2013; 382: 1073-4.
9. th November 2013.
10. United States Department of Health and Human Services. Code of Federal Regulations. Title 45: public welfare, Subtitle A §164.514, 2011 Edition). Available from http://www.gpo.gov/fdsys/pkg/CFR-2011-title45-vol1/pdf/CFR-2011- title45-vol1-sec164-514.pdf, last accessed 15th November 2013.
11. Hrynaszkiewicz I, Norton ML, et al., Preparing raw clinical data for publication: guidance for journal editors, authors, and peer reviewers. British Medical Journal 2010; 340: 304-307.
12. th November 2013.
13. th November 2013.
14. th November 2013.